Abbott Laboratories (ABT)

NYSE Health Care Health Care Equipment S&P 500

$109.93

-3.67 (-3.23%)

Close of Nov 06, 2026 · end-of-day data

Source: Abbott Laboratories's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$20.85B	$27.39B	$30.58B	$31.90B	$34.61B	$43.08B	$43.65B	$40.11B	$41.95B	$44.33B
Cost of revenue	$9.09B	$12.41B	$12.71B	$13.23B	$15.00B	$18.54B	$19.14B	$17.98B	$18.71B	$19.32B
Gross profit	$11.76B	$14.98B	$17.87B	$18.67B	$19.61B	$24.54B	$24.51B	$22.13B	$23.24B	$25.01B
Research & development	$1.45B	$2.26B	$2.30B	$2.44B	$2.42B	$2.74B	$2.89B	$2.74B	$2.84B	$2.94B
Selling, general & admin	$6.74B	$9.18B	$9.74B	$9.77B	$9.70B	$11.32B	$11.25B	$10.95B	$11.70B	$12.33B
Operating income	$3.03B	$1.56B	$3.65B	$4.53B	$5.36B	$8.43B	$8.36B	$6.48B	$6.83B	$8.05B
Interest expense	$431.00M	$904.00M	$826.00M	$670.00M	$546.00M	$533.00M	$558.00M	$637.00M	$559.00M	$493.00M
Pre-tax income	$1.41B	$2.23B	$2.87B	$4.08B	$4.97B	$8.21B	$8.31B	$6.66B	$7.01B	$8.47B
Income tax	$350.00M	$1.88B	$539.00M	$390.00M	$497.00M	$1.14B	$1.37B	$941.00M	-$6.39B	$1.94B
Net income	$1.40B	$477.00M	$2.37B	$3.69B	$4.50B	$7.07B	$6.93B	$5.72B	$13.40B	$6.52B
EBITDA	$3.83B	$2.61B	$4.75B	$5.61B	$6.55B	$9.92B	$9.62B	$7.75B	$8.16B	$9.49B
EPS (basic)	$0.94	$0.27	$1.34	$2.07	$2.52	$3.97	$3.94	$3.28	$7.67	$3.73
EPS (diluted)	$0.94	$0.27	$1.33	$2.06	$2.50	$3.94	$3.91	$3.26	$7.64	$3.72
Diluted shares	1.48B	1.75B	1.77B	1.78B	1.79B	1.79B	1.76B	1.75B	1.75B	1.75B
Gross margin	56.4%	54.7%	58.4%	58.5%	56.6%	57.0%	56.1%	55.2%	55.4%	56.4%
Operating margin	14.5%	5.7%	11.9%	14.2%	15.5%	19.6%	19.2%	16.2%	16.3%	18.2%
Net margin	6.7%	1.7%	7.7%	11.6%	13.0%	16.4%	15.9%	14.3%	31.9%	14.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$18.62B	$9.41B	$3.84B	$3.86B	$6.84B	$9.80B	$9.88B	$6.90B	$7.62B	$8.52B
Short-term investments	$155.00M	$203.00M	$242.00M	$280.00M	$310.00M	$450.00M	$288.00M	$383.00M	$351.00M	$417.00M
Receivables	$3.25B	$5.25B	$5.18B	$5.42B	$6.41B	$6.49B	$6.22B	$6.57B	$6.92B	$7.93B
Inventory	$2.43B	$3.60B	$3.80B	$4.32B	$5.01B	$5.16B	$6.17B	$6.57B	$6.19B	$6.49B
Total current assets	$26.78B	$20.15B	$14.63B	$15.67B	$20.44B	$24.24B	$25.22B	$22.67B	$23.66B	$26.00B
Goodwill	$7.68B	$24.02B	$23.25B	$23.20B	$23.74B	$23.23B	$22.80B	$23.68B	$23.11B	$24.04B
Total assets	$52.67B	$76.25B	$67.17B	$67.89B	$72.55B	$75.20B	$74.44B	$73.21B	$81.41B	$86.71B
Total current liabilities	$6.66B	$8.91B	$9.01B	$10.86B	$11.91B	$13.11B	$15.49B	$13.84B	$14.16B	$16.50B
Short-term debt	$3.00M	$508.00M	$7.00M	$1.28B	$7.00M	$754.00M	$2.25B	$1.08B	$1.50B	$3.03B
Long-term debt	$20.68B	$27.21B	$19.36B	$16.66B	$18.53B	$17.30B	$14.52B	$13.60B	$12.62B	$9.90B
Total debt	$20.68B	$27.72B	$19.37B	$17.94B	$18.53B	$18.05B	$16.77B	$14.68B	$14.12B	$12.93B
Total liabilities	$32.13B	$45.35B	$36.65B	$36.80B	$39.76B	$39.39B	$37.75B	$34.61B	$33.75B	$34.58B
Shareholders' equity	$20.54B	$30.90B	$30.52B	$31.09B	$32.78B	$35.80B	$36.69B	$38.60B	$47.66B	$52.13B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$3.20B	$5.57B	$6.30B	$6.14B	$7.90B	$10.53B	$9.58B	$7.26B	$8.56B	$9.57B
Capital expenditures	$1.12B	$1.14B	$1.39B	$1.64B	$2.18B	$1.89B	$1.78B	$2.20B	$2.21B	$2.17B
Free cash flow	$2.08B	$4.43B	$4.91B	$4.50B	$5.72B	$8.65B	$7.80B	$5.06B	$6.35B	$7.39B
Investing cash flow	-$248.00M	-$9.62B	-$1.36B	-$1.81B	-$2.21B	-$2.01B	-$1.74B	-$3.13B	-$2.34B	-$2.42B
Financing cash flow	$11.15B	-$5.28B	-$10.39B	-$4.29B	-$2.78B	-$5.49B	-$7.64B	-$7.09B	-$5.40B	-$6.31B
Dividends paid	$1.54B	$1.85B	$1.97B	$2.27B	$2.56B	$3.20B	$3.31B	$3.56B	$3.84B	$4.12B
Share buybacks	$522.00M	$117.00M	$238.00M	$718.00M	$403.00M	$2.30B	$3.79B	$1.23B	$1.29B	$893.00M
Stock-based compensation	$310.00M	$406.00M	$477.00M	$519.00M	$546.00M	$640.00M	$685.00M	$644.00M	$673.00M	$664.00M
Depreciation & amortization	$803.00M	$1.05B	$1.10B	$1.08B	$1.20B	$1.49B	$1.25B	$1.28B	$1.34B	$1.43B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$10.24B	$9.96B	$10.38B	$10.63B	$10.97B	$10.36B	$11.14B	$11.37B	$11.46B	$11.16B	$12.59B	$13.01B
Cost of revenue	$4.56B	$4.46B	$4.60B	$4.70B	$4.94B	$4.47B	$4.85B	$5.08B	$4.92B	$4.89B	$5.33B	$5.63B
Gross profit	$5.68B	$5.50B	$5.77B	$5.94B	$6.03B	$5.89B	$6.29B	$6.29B	$6.54B	$6.27B	$7.27B	$7.38B
Research & development	$700.00M	$684.00M	$698.00M	$713.00M	$749.00M	$716.00M	$725.00M	$766.00M	$735.00M	$767.00M	$892.00M	$920.00M
Selling, general & admin	$2.72B	$2.96B	$2.94B	$2.90B	$2.91B	$3.06B	$3.09B	$3.05B	$3.13B	$3.74B	$4.03B	$4.27B
Operating income	$1.78B	$1.39B	$1.67B	$1.86B	$1.91B	$1.69B	$2.05B	$2.06B	$2.25B	$1.34B	$1.69B	$1.36B
Interest expense	$159.00M	$141.00M	$140.00M	$142.00M	$136.00M	$131.00M	$121.00M	$121.00M	$120.00M	$174.00M	$351.00M	$350.00M
Pre-tax income	$1.79B	$1.44B	$1.61B	$1.94B	$2.03B	$1.78B	$2.15B	$2.18B	$2.36B	$1.45B	$1.52B	$1.23B
Income tax	$201.00M	$211.00M	$305.00M	$294.00M	-$7.20B	$453.00M	$371.00M	$536.00M	$582.00M	$372.00M	$596.00M	$311.00M
Net income	$1.59B	$1.23B	$1.30B	$1.65B	$9.23B	$1.32B	$1.78B	$1.64B	$1.78B	$1.08B	$928.00M	$920.00M
EBITDA	$2.11B	$1.72B	$2.00B	$2.19B	$2.25B	$2.03B	$2.41B	$2.43B	$2.62B	$1.73B	$2.10B	$1.77B
EPS (basic)	$0.92	$0.70	$0.74	$0.94	$5.28	$0.76	$1.02	$0.94	$1.01	$0.62	$0.53	$0.53
EPS (diluted)	$0.91	$0.70	$0.74	$0.94	$5.26	$0.76	$1.01	$0.94	$1.02	$0.61	$0.53	$0.53
Diluted shares	-1.07M	1.75B	1.75B	1.75B	-1.43M	1.75B	1.75B	1.75B	-1.16M	1.75B	1.74B	1.74B
Gross margin	55.5%	55.2%	55.6%	55.8%	55.0%	56.9%	56.4%	55.4%	57.0%	56.2%	57.7%	56.8%
Operating margin	17.4%	13.9%	16.1%	17.5%	17.4%	16.3%	18.4%	18.1%	19.6%	12.0%	13.4%	10.4%
Net margin	15.6%	12.3%	12.5%	15.5%	84.1%	12.8%	16.0%	14.5%	15.5%	9.6%	7.4%	7.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$6.90B	$6.28B	$6.99B	$7.56B	$7.62B	$6.53B	$6.95B	$7.51B	$8.52B	$6.80B	$5.10B	$4.05B
Short-term investments	$383.00M	$367.00M	$232.00M	$230.00M	$351.00M	$312.00M	$331.00M	$222.00M	$417.00M	$492.00M	$499.00M	$246.00M
Receivables	$6.57B	$6.61B	$6.85B	$7.05B	$6.92B	$7.33B	$7.97B	$8.14B	$7.93B	$8.21B	$8.60B	$9.03B
Inventory	$6.57B	$6.83B	$6.81B	$6.81B	$6.19B	$6.64B	$6.95B	$6.71B	$6.49B	$6.99B	$7.32B	$7.34B
Total current assets	$22.67B	$22.38B	$23.12B	$23.80B	$23.66B	$23.15B	$24.47B	$24.84B	$26.00B	$25.51B	$24.52B	$23.50B
Goodwill	$23.68B	$23.38B	$23.31B	$23.66B	$23.11B	$23.36B	$23.95B	$23.97B	$24.04B	$35.22B	$35.24B	$32.64B
Total assets	$73.21B	$72.47B	$73.02B	$74.36B	$81.41B	$81.45B	$84.00B	$84.18B	$86.71B	$110.43B	$109.22B	$108.25B
Total current liabilities	$13.84B	$14.02B	$13.76B	$14.90B	$14.16B	$13.00B	$13.44B	$14.58B	$16.50B	$18.38B	$17.81B	$16.15B
Short-term debt	$1.08B	$2.01B	$1.61B	$2.15B	$1.50B	$506.00M	$507.00M	$1.34B	$3.03B	$4.41B	$3.00B	$1.71B
Long-term debt	$13.60B	$12.58B	$13.14B	$12.82B	$12.62B	$12.74B	$12.93B	$11.60B	$9.90B	$29.64B	$29.60B	$29.45B
Total debt	$14.68B	$14.59B	$14.75B	$14.98B	$14.12B	$13.24B	$13.44B	$12.94B	$12.93B	$34.05B	$32.61B	$31.16B
Total liabilities	$34.61B	$33.66B	$33.70B	$34.56B	$33.75B	$32.64B	$33.43B	$33.23B	$34.58B	$58.37B	$58.10B	$57.22B
Shareholders' equity	$38.60B	$38.81B	$39.32B	$39.80B	$47.66B	$48.81B	$50.56B	$50.95B	$52.13B	$52.06B	$51.11B	$51.03B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$3.04B	$1.02B	$1.96B	$2.71B	$2.87B	$1.42B	$2.05B	$2.79B	$3.31B	$1.31B	$2.49B	$1.74B
Capital expenditures	$755.00M	$398.00M	$533.00M	$556.00M	$720.00M	$484.00M	$502.00M	$496.00M	$689.00M	$399.00M	$497.00M	$513.00M
Free cash flow	$2.28B	$627.00M	$1.43B	$2.15B	$2.15B	$933.00M	$1.54B	$2.29B	$2.63B	$916.00M	$1.99B	$1.22B
Investing cash flow	-$824.00M	-$425.00M	-$453.00M	-$594.00M	-$866.00M	-$470.00M	-$582.00M	-$457.00M	-$913.00M	-$20.32B	-$673.00M	-$385.00M
Financing cash flow	-$2.05B	-$1.18B	-$791.00M	-$1.58B	-$1.86B	-$2.06B	-$1.10B	-$1.76B	-$1.40B	$17.31B	-$3.52B	-$2.40B
Dividends paid	$888.00M	$957.00M	$961.00M	$960.00M	$958.00M	$1.03B	$1.03B	$1.03B	$1.03B	$1.10B	$1.10B	$1.09B
Share buybacks	$259.00M	$226.00M	$3.00M	$751.00M	$315.00M	$280.00M	$6.00M	$305.00M	$302.00M	$180.00M	$1.04B	$11.00M
Stock-based compensation	$114.00M	$304.00M	$141.00M	$117.00M	$111.00M	$289.00M	$142.00M	$120.00M	$113.00M	$317.00M	$168.00M	$137.00M
Depreciation & amortization	$332.00M	$333.00M	$334.00M	$331.00M	$342.00M	$336.00M	$357.00M	$371.00M	$370.00M	$381.00M	$402.00M	$415.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.